Sellas Life Sciences Group Inc (SLS)
Operating Cash Flow (Statement)
-$28.42M
TTM · Period ending: · USD
SLS Operating Cash Flow (Statement)
Latest reported-$28.42Mperiod ending
Latest reported-$28.42Mperiod ending
SLS Cash from Operations (-$2.11M → -$28.42M)
Annual operating cash flow (statement)
High-resolution chart · PNG
SLS operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -28,389,000 | |
| -35,402,000 | |
| -31,410,000 | |
| -23,809,000 | |
| -26,021,000 | |
| -10,417,000 | |
| -17,643,000 | |
| -30,422,000 | |
| -10,989,000 | |
| -44,915,000 | |
| -48,160,000 | |
| -42,869,000 | |
| -28,908,000 | |
| -20,963,000 | |
| -14,668,000 | |
| -10,257,000 | |
| -11,769,000 | |
| -9,429,000 | |
| -6,047,000 | |
| -2,112,000 |